Navigation Links
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Date:1/24/2008

- U.S. Data Highlights Oral Xeloda versus Standard Infusional Chemotherapy

in Gastroesophageal and Colorectal Cancers -

NUTLEY, N.J., Jan. 24 /PRNewswire/ -- Roche announced today that a total of 33 abstracts involving its oral chemotherapy Xeloda(R) have been accepted for presentation at the 2008 Gastrointestinal Cancers Symposium in Orlando, Fla., from Jan. 25 to 27.

Five poster presentations based on U.S. data offer additional knowledge about Xeloda. Two of these U.S. abstracts compare the safety profile and usage patterns of therapy with oral Xeloda to that of intravenous fluorouracil (5-FU) therapy in gastroesophageal cancer. A second pair of U.S. abstracts evaluates the usage patterns and cost of Xeloda-based regimens against those of 5-FU-based regimens in colon and rectal cancer. The fifth U.S. abstract highlights preclinical efficacy and tolerability results of a novel Xeloda regimen (7/7, or 7 days on, 7 days off) using higher daily doses for the treatment of colorectal cancer.
-- Jan. 25, noon to 1 p.m., [Poster No. 72], A claims database analysis of

capecitabine treatment patterns in patients with gastroesophageal

cancer (GEC) (Presenter: Wasif Saif)

-- Jan. 25, noon to 1 p.m., [Poster No. 71], Capecitabine in patients with

gastroesophageal cancer (GEC): A claims database analysis of adverse

events (AEs) (Presenter: Wasif Saif)

-- Jan. 26, 5:30 to 6:30 p.m., [Poster No. 364], A claims database cost-

comparison analysis of capecitabine in the treatment of patients with

colon or rectal cancer (CRC) (Presenter: Edward Chu)

-- Jan. 27, 7 to 8 a.m., [Poster No. 465], Capecitabine use in patients

with colon and rectal cancer (CRC): A claims database analysis of

treatment (Presenter: Edward Chu)

-- Jan. 27, 7 to 8 a.m., [Poster No. A29], In vivo activity of traditional

vs. novel regimens of capecitabine (C) alon
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
2. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
3. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
4. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
5. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
6. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
7. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
8. Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
9. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... Oct. 17, 2014 Research and ... "Research and Development Prospect of China Dialysis Market, ... Based on the 2013 version, this update ... about dialysis industry and the relevant effect in ... dialysis industry segmentations. Moreover, it analyzes Chinese private-owned ...
(Date:10/17/2014)... BALTIMORE, Md. , Oct. 17, 2014 /PRNewswire-USNewswire/ ... Center for Medical Technology Policy: The ... from the FDA, public and private payers, medical ... representatives, clinicians, and other experts January 12, 2015 ... effectiveness and value of weight loss treatments.  Participants ...
(Date:10/17/2014)... 2014  China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... received approval from the China Food and Drug ... prothrombin complex concentrate ("PCC") at its Shandong Taibang ... factor production facility for Good Manufacturing Practices ("GMP") ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... N.J., Nov. 10, 2011 Nephros, Inc. (OTC Bulletin Board: ... initial review by the Food and Drug Administration ("FDA") of ... system. On August 11, 2011 Nephros submitted a ... end-stage renal disease.  On November 8, 2011 Nephros received the ...
... ARAY ), the premier radiation oncology company, announced ... Thomson, Ph.D., is scheduled to present at the Lazard Capital ... Tuesday November 15, 2011 at 10:30 a.m. EST/7:30 a.m. PST. ... Fall Investment Conference in New York City on Wednesday November ...
Cached Medicine Technology:Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 2Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 3Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System 4
(Date:10/20/2014)... York, NY (PRWEB) October 20, 2014 ... based non-profit organization that helps New Yorkers living ... positive changes toward health, housing, recovery and self-sufficiency. ... have transformed the local community through their tireless ... Director, Marc Shapses , has been selected ...
(Date:10/20/2014)... 2014 JZ Fitness, an independently operated ... wellness programming, authorship, international lecturing and community wellness, created ... the release of the JZ Fitness nutrition app, available ... coaching thousands of individuals on nutrition, Jenn Zerling (“JZ”) ... not require calorie counting or cumbersome food logging. ...
(Date:10/20/2014)... 2014 Rockynol Retirement Community ... Oct. 14. The $11 million project will include the ... cooked-to-order kitchen with full-service restaurant style dining. , “We ... first class Assisted Living apartments,” said Kara Hanzie, Rockynol ... highest quality of care and this investment is proof ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Unveiled at the ... Strategic Direction Scorecard conservatively estimates member hospital ROI on membership ... on dues, The Center provides $12.50 in value to member ... (Member Value – Member Dues)/Member Dues. , “This is ... this number and we think the methodology is really sound,” ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal injury ... the greater Phoenix area and across Arizona reports record ... catastrophic automobile accidents. Statistics have indicated a steady increase ... As such, Hastings and Hastings has seen a steady ... who have been injured through no fault of their ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
... speaks to you, do you see what they are saying? ... hear, but recent studies suggest that we use a variety ... speech as something we hear, see and even feel. In ... , a journal of the Association for Psychological Science, psychologist ...
... quality care at Cancer Treatment Centers of America ... of America (CTCA) has opened the nation,s first ... facility is the fourth hospital in the steadily ... Medical Center (Western) extends the comprehensive electronic health ...
... 11 /PRNewswire-USNewswire/ -- The U.S. House of ... Assisted Living Federation of America to help law ... Alert Act (H.R. 632), authored by Congressman Lloyd ... vote."We commend Congressman Doggett for his leadership. This ...
... enable more time for direct resident care, ... increase staff satisfactionPITTSBURGH, Feb. 11 Vocollect ... Partners Management Group (Preferred Care) headquartered in ... in two of its managed skilled nursing ...
... efficacy a building block for health reformWASHINGTON, Feb. ... America,s Health Insurance Plans (AHIP), today issued the ... in the Senate-passed stimulus bill:"At a time when ... serious concern for many Americans, it is critical ...
... Brain sees these as special events, even though result ... News) -- A near-win in gambling stimulates a large ... boosts a person,s motivation to gamble, according to British ... explain why gambling attracts so many people and why ...
Cached Medicine News:Health News:Read my lips: Using multiple senses in speech perception 2Health News:Electronic Health Record Advances Patient-Centered Cancer Care at Cancer Treatment Centers of America 2Health News:Electronic Health Record Advances Patient-Centered Cancer Care at Cancer Treatment Centers of America 3Health News:House Passes ALFA-Supported National Silver Alert Bill 2Health News:Preferred Care Partners Management Group Deploys Voice-Assisted Care 2Health News:Preferred Care Partners Management Group Deploys Voice-Assisted Care 3Health News:'Near-Wins' Boost Desire to Keep Gambling 2
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
Medicine Products: